Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H34N2O70S16.16Na |
Molecular Weight | 2387.407 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[H][C@@]2(O[C@H]([C@@H](COS([O-])(=O)=O)OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)C(=O)NCCCNC(=O)[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@H](O[C@]1([H])O[C@H](COS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@H]1OS([O-])(=O)=O)[C@@H](COS([O-])(=O)=O)OS([O-])(=O)=O)O[C@H](COS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@H]2OS([O-])(=O)=O
InChI
InChIKey=CXKOATPJKFZCEL-HPXJARCXSA-A
InChI=1S/C27H50N2O70S16.16Na/c30-24(20(96-112(68,69)70)16(92-108(56,57)58)12(10(88-104(44,45)46)6-82-102(38,39)40)86-26-22(98-114(74,75)76)18(94-110(62,63)64)14(90-106(50,51)52)8(84-26)4-80-100(32,33)34)28-2-1-3-29-25(31)21(97-113(71,72)73)17(93-109(59,60)61)13(11(89-105(47,48)49)7-83-103(41,42)43)87-27-23(99-115(77,78)79)19(95-111(65,66)67)15(91-107(53,54)55)9(85-27)5-81-101(35,36)37;;;;;;;;;;;;;;;;/h8-23,26-27H,1-7H2,(H,28,30)(H,29,31)(H,32,33,34)(H,35,36,37)(H,38,39,40)(H,41,42,43)(H,44,45,46)(H,47,48,49)(H,50,51,52)(H,53,54,55)(H,56,57,58)(H,59,60,61)(H,62,63,64)(H,65,66,67)(H,68,69,70)(H,71,72,73)(H,74,75,76)(H,77,78,79);;;;;;;;;;;;;;;;/q;16*+1/p-16/t8-,9-,10-,11-,12-,13-,14+,15+,16+,17+,18+,19+,20-,21-,22-,23-,26+,27+;;;;;;;;;;;;;;;;/m1................/s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C27H34N2O70S16 |
Molecular Weight | 2019.57 |
Charge | -16 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Phase I--study with aprosulate, a new synthetic anticoagulant. | 1993 Oct 15 |
|
Protamine sulfate neutralization of the anticoagulant activity of Aprosulate, a synthetic sulfated lactobionic acid amide. | 1994 Mar 1 |
|
Anticoagulant and antiprotease activities of aprosulate sodium, a new synthetic polyanion, in human plasma and purified systems. | 1994 Oct |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8303655
Twelve healthy male volunteers received subcutaneous injections of placebo on the first day followed by ascending doses of aprosulate in the range of 0.25 mg/kg to 2.0 mg/kg body weight on alternate days.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8950791
Aprosulate inhibited thrombin (0.03-0.3 U/ml)-induced aggregation in rat washed platelets in a concentration-dependent manner, with an IC50 value of 0.38 ug/ml. In contrast, aprosulate, at up to 10 ug/ml, did not affect collagen (1 ug/ml)- or ADP (3 uM)-induced aggregation. In fura 2-loaded platelets, aprosulate (1-10 ug/ml) inhibited intracellular Ca2+ mobilization induced by thrombin, but not that by ADP.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:13:47 GMT 2023
by
admin
on
Fri Dec 15 16:13:47 GMT 2023
|
Record UNII |
311154J4LN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C263
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB05545MIG
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
123072-45-7
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
6660
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
100000087183
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
311154J4LN
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
72125
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
DTXSID90904508
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
C77990
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110864
Created by
admin on Fri Dec 15 16:13:48 GMT 2023 , Edited by admin on Fri Dec 15 16:13:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |